GENEDX, LLC

GENEDX, LLC specializes in advanced genetic diagnostic testing services, primarily delivering targeted next-generation sequencing and copy number variant (CNV) analysis for hereditary hematologic disorders such as myelodysplastic syndromes and leukemias. Their technical expertise centers on clinical-grade molecular diagnostics, including mutation profiling, genomic variant interpretation, and precision oncology testing platforms designed for underserved patient populations. The contractor’s work supports actionable clinical decision-making through high-complexity laboratory workflows compliant with CLIA and CAP standards, with a demonstrated focus on expanding access to genetic testing for populations lacking routine diagnostic resources. The company maintains a consistent and deep relationship with the Department of Health and Human Services, providing specialized genetic analysis services under federal health initiatives. Their engagements typically involve supporting public health programs through the delivery of inherited disease panels, longitudinal mutation tracking, and diagnostic confirmation services, often in alignment with HHS objectives to advance equitable access to genomic medicine. GENEDX, LLC operates exclusively within the Medical Laboratories NAICS category (621511), positioning itself as a niche provider of clinical genomics services within the federal healthcare ecosystem. Their market focus is on hereditary cancer and hematologic disorder diagnostics, serving as a critical technical partner for agencies deploying precision medicine frameworks. They do not offer broad-spectrum laboratory services but instead concentrate on high-complexity, targeted genomic assays with direct clinical utility. As a small business structured as a 2L entity based in Gaithersburg, Maryland, GENEDX, LLC maintains a focused operational footprint aligned with federal biomedical research and public health priorities. While currently holding no formal government certifications, their work is conducted within the regulatory framework of clinical laboratory accreditation, ensuring compliance with federal standards for diagnostic testing. Their geographic location supports proximity to key federal health agencies and research institutions in the National Capital Region.